SAN FRANCISCO, May 8 /PRNewswire-FirstCall/ -- VIA Pharmaceuticals
(Nasdaq: VIAP), a biotechnology company focused on the development of
compounds for the treatment of cardiovascular disease, announced today that
James G. Stewart, senior vice president and chief financial officer, will
present a company update at the Rodman & Renshaw 5th Annual Global
Healthcare Conference on Monday, May 19, 2008 at 11:50 a.m. CEST at Le
Meridien Beach Plaza Hotel in Monte Carlo, Monaco.
Interested parties may access a live audio webcast of the presentation from the investor section of the VIA website, http://www.viapharmaceuticals.com or at http://www.wsw.com/webcast/rrshq13/viap. A replay of the presentation will be archived on the VIA website for at least one week following the presentation. About VIA Pharmaceuticals, Inc.
VIA Pharmaceuticals, Inc. is a biotechnology company focused on the development of compounds for the treatment of cardiovascular disease. VIA is building a pipeline of small-molecule drugs that target a significant unmet medical need: reducing inflammation in the blood vessel wall, which is an underlying cause of atherosclerosis and its complications, including heart attack and stroke. The company's lead drug candidate, VIA-2291, is in multiple Phase 2 clinical studies in patients with cardiovascular disease. For more information, visit: http://www.viapharmaceuticals.com.
|SOURCE VIA Pharmaceuticals, Inc.|
Copyright©2008 PR Newswire.
All rights reserved